Interestingly, the combination of DDX5 and fructose-bisphosphate aldolase A (ALDOA), which played a key role in glycolysis and gluconeogenesis, had more significant prognostic values in CRC patients (124). This evidence concerns the gene DDX5 and colorectal carcinoma.